MSN Labs, is one of the global leaders in the development and manufacturing of APIs (active pharmaceutical ingredients). The process of API development must include the primary components called KSMs (key starting materials) and product intermediates. These “building blocks” of API are often sourced by generic pharma companies (who may claim to be vertically integrated) through third party companies who develop and manufacture them. MSN is vertically integrated with APIs but is also “backward integrated” with KSMs and intermediates for the majority of our products. This ensures our manufacturing process for API utilizes products that are sourced directly through our internal manufacturing facilities.
MSN has deeply invested in these critical components with FDA accredited sites that are subject to inspections, and used exclusively for their manufacturing. These facilities have FDA approved back-up sites, to meet the growing demand for our products and have further enhanced the organization’s reputation as a leader in the API category.